LAURA PORTER: Open Payments
NPI 1639877640 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 27 payments from 9 companies in 2025. Trend: 2023 $116 · 2024 $857 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Corium, LLC | 7 | $122 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Alkermes, Inc. | 2 | $39 |
| Tris Pharma Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Azstarys, REXULTI, Auvelity, FANAPT, LYBALVI, Dyanavel XR, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
